Evidence map›Paper›PMID 32405060›Full record

ArticleNature medicine2020

A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors.

Michal Slyper, Caroline B M Porter, Orr Ashenberg, Julia Waldman, Eugene Drokhlyansky, Isaac Wakiro, Christopher Smillie, Gabriela Smith-Rosario, Jingyi Wu, Danielle Dionne and 40 more

Erratum issuedAbstract readEvaluation Study
In one paragraph

Article in Nature medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 475 papers.

0numbers the graph read from it
0cells of the map it votes in
475citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

475 citing papers in PubMed.

  1. Cambridge Neoadjuvant Cancer of the Prostate (CANCAP03): A Window Study into the Effects of Olaparib ± Degarelix in Primary Prostate Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Distinct single-nucleus RNA-seq changes among non-neuronal cells in ADNC, LATE-NC, and mixed pathologies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

415 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

50 authors.

Michal Slyper *Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Caroline B M Porter *Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Orr Ashenberg *Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Julia WaldmanKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Eugene DrokhlyanskyKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Isaac WakiroBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Christopher SmillieKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Gabriela Smith-RosarioKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Jingyi WuBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Danielle DionneKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Sébastien VigneauBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Judit Jané-ValbuenaKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Timothy L TickleKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Sara NapolitanoBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Mei-Ju SuBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Anand G PatelDepartment of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-1438-8275
Asa KarlstromDepartment of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0003-3847-7309
Simon GritschDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Masashi NomuraDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0001-6095-7849
Avinash WaghrayCenter for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.
Satyen H GohilBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Alexander M TsankovKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Livnat Jerby-ArnonKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Ofir CohenBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Johanna KlughammerKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Yanay RosenKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Joshua GouldKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-9581-5461
Lan NguyenKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Matan HofreeKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Peter J TramontozziDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-5540-0111
Bo LiBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Catherine J WuBroad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-3348-5054
Benjamin IzarBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Rizwan HaqBroad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-1290-9276
F Stephen HodiDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Charles H YoonDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Aaron N HataCenter for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Suzanne J BakerDepartment of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN, USA.
Mario L SuvàBroad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-9898-5351
Raphael BuenoDivision of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Elizabeth H StoverBroad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-6578-3216
Michael R ClayDepartment of Pathology, St Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0003-1659-8927
Michael A DyerDepartment of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN, USA.
Natalie B CollinsBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Ursula A MatulonisDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nikhil WagleBroad Institute of Harvard and MIT, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-3332-9438
Bruce E JohnsonDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Asaf RotemBroad Institute of Harvard and MIT, Cambridge, MA, USA.
Orit Rozenblatt-RosenKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA. orit@broadinstitute.org.ORCID http://orcid.org/0000-0001-6313-3570
Aviv RegevKlarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, USA. aregev@broadinstitute.org.ORCID http://orcid.org/0000-0003-3293-3158

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Mark Joseph Daly · 1991 to 2026
$35.3M
Investigating Human Adipocyte HeterogeneityRC2DK116691 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Orr Ashenberg, Noel P Burtt · 2018 to 2026
$17.8M
The Cellular Geography of Therapeutic Resistance in CancerU2CCA233195 · NCI · DANA-FARBER CANCER INST · PI JOHNSON, BRUCE E. · 2018 to 2023
$13.7M
The LungMAP Data Coordination Center for Next Gen Systems Biology of RespirationU24HL148865 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI Bruce J Aronow, Nathan G. Salomonis · 2019 to 2026
$12.4M
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule DrugsU54CA225088 · NCI · HARVARD MEDICAL SCHOOL · PI SORGER, PETER KARL · 2018 to 2022
$10.8M
Personal tumor neoantigens for immunity against chronic lymphocytic leukemiaR01CA155010 · NCI · DANA-FARBER CANCER INST · PI Catherine Ju-Ying Wu · 2011 to 2026
$9.6M
LungMap Phase II - Building a multidimensional map of developing human lungU01HL148856 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI WHITSETT, JEFFREY A, XU, YAN · 2019 to 2023
$4.5M
The roles of anti-apoptotic proteins BCL-XL and MCL1 in mediating survival of high-grade serous ovarian cancer following drug-induced DNA damageK08CA237871 · NCI · DANA-FARBER CANCER INST · PI STOVER, ELIZABETH HARMON · 2019 to 2023
$921k
Dissecting mechanisms of immunotherapy resistance in melanoma patientsK08CA222663 · NCI · DANA-FARBER CANCER INST · PI IZAR, BENJAMIN · 2017 to 2021
$827k
NCI NIH HHS HHSN261201500003CNCI NIH HHS HHSN261201500003INCI NIH HHS K08 CA222663NCI NIH HHS K08 CA237871NCI NIH HHS R01 CA155010NCI NIH HHS U2C CA233195NCI NIH HHS U54 CA225088NHLBI NIH HHS U01 HL148856NHLBI NIH HHS U24 HL148865NIDDK NIH HHS P30 DK043351NIDDK NIH HHS RC2 DK116691
6 · The paper itself

Abstract

Single-cell genomics is essential to chart tumor ecosystems. Although single-cell RNA-Seq (scRNA-Seq) profiles RNA from cells dissociated from fresh tumors, single-nucleus RNA-Seq (snRNA-Seq) is needed to profile frozen or hard-to-dissociate tumors. Each requires customization to different tissue and tumor types, posing a barrier to adoption. Here, we have developed a systematic toolbox for profiling fresh and frozen clinical tumor samples using scRNA-Seq and snRNA-Seq, respectively. We analyzed 216,490 cells and nuclei from 40 samples across 23 specimens spanning eight tumor types of varying tissue and sample characteristics. We evaluated protocols by cell and nucleus quality, recovery rate and cellular composition. scRNA-Seq and snRNA-Seq from matched samples recovered the same cell types, but at different proportions. Our work provides guidance for studies in a broad range of tumors, including criteria for testing and selecting methods from the toolbox for other tumors, thus paving the way for charting tumor atlases.

Indexed as

AlgorithmsAdultAnimalsCell NucleusChildComputational BiologyExome SequencingFemaleFreezingGene Expression ProfilingGene Expression Regulation, NeoplasticGenomicsHumansMiceMice, KnockoutMice, Nude

Identifiers

PMID32405060
PMCPMC7220853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.